Efficient radiosynthesis and preclinical evaluation of [18F]FOMPyD as a positron emission tomography tracer candidate for TrkB/C receptor imaging

被引:7
|
作者
Singleton, Thomas A. [1 ]
Bdair, Hussein [1 ,4 ]
Bailey, Justin J. [2 ]
Choi, Sangho [2 ]
Aliaga, Arturo [3 ]
Rosa-Neto, Pedro [1 ,3 ,4 ]
Schirrmacher, Ralf [2 ]
Bernard-Gauthier, Vadim [2 ]
Kostikov, Alexey [1 ,4 ]
机构
[1] McGill Univ, McConnell Brain Imaging Ctr, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada
[2] Univ Alberta, Dept Oncol, Div Oncol Imaging, Edmonton, AB, Canada
[3] Douglas Mental Hlth Univ Inst, McGill Ctr Studies Aging, Translat Neuroimaging Lab, Montreal, PQ, Canada
[4] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada
关键词
F-18]FOMPyD; brain imaging; colony stimulating factor receptor (CSF-1R); copper-mediated F-18-fluorination; fluorine-18; GW2580; PET; positron emission tomography; tropomyosin receptor kinase (Trk); INHIBITOR;
D O I
10.1002/jlcr.3827
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Herein we report an efficient radiolabeling of a F-18-fluorinated derivative of dual inhibitor GW2580, with its subsequent evaluation as a positron emission tomography (PET) tracer candidate for imaging of two neuroreceptor targets implicated in the pathophysiology of neurodegeneration: tropomyosin receptor kinases (TrkB/C) and colony stimulating factor receptor (CSF-1R). [F-18]FOMPyD was synthesized from a boronic acid pinacolate precursor via copper-mediated F-18-fluorination concerted with thermal deprotection of the four Boc groups on a diaminopyrimidine moiety in an 8.7 +/- 2.8% radiochemical yield, a radiochemical purity >99%, and an effective molar activity of 187 +/- 93 GBq/mu mol. [F-18]FOMPyD showed moderate brain permeability in wild-type rats (SUVmax = 0.75) and a slow washout rate. The brain uptake was partially reduced (Delta AUC(40-90) = 11.6%) by administration of the nonradioactive FOMPyD (up to 30 mu g/kg). In autoradiography, [F-18]FOMPyD exhibits ubiquitous distribution in rat and human brain tissues with relatively high nonspecific binding revealed by self-blocking experiment. The binding was blocked by TrkB/C inhibitors, but not with a CSF-1R inhibitor, suggesting selective binding to the former receptor. Although an unfavorable pharmacokinetic profile will likely preclude application of [F-18]FOMPyD as a PET tracer for brain imaging, the concomitant one-pot copper-mediated F-18-fluorination/Boc-deprotection is a practical technique for the automated radiosynthesis of acid-sensitive PET tracers.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 50 条
  • [1] Steroids labeled with 18F for imaging tumors by positron emission tomography
    Katzenellenbogen, JA
    JOURNAL OF FLUORINE CHEMISTRY, 2001, 109 (01) : 49 - 54
  • [2] Radiosynthesis and In Vivo Evaluation of Four Positron Emission Tomography Tracer Candidates for Imaging of Melatonin Receptors
    Bdair, Hussein
    Singleton, Thomas A.
    Ross, Karen
    Jolly, Dean
    Kang, Min Su
    Aliaga, Arturo
    Tuznik, Marius
    Kaur, Tanpreet
    Yous, Said
    Soucy, Jean-Paul
    Massarweh, Gassan
    Scott, Peter J. H.
    Koeppe, Robert
    Spadoni, Gilberto
    Bedini, Annalida
    Rudko, David A.
    Gobbi, Gabriella
    Benkelfat, Chawki
    Rosa-Neto, Pedro
    Brooks, Allen F.
    Kostikov, Alexey
    ACS CHEMICAL NEUROSCIENCE, 2022, 13 (09): : 1382 - 1394
  • [3] Highly Efficient Radiosynthesis and Biological Evaluation of [18F]Safinamide, a Radiolabelled Anti-Parkinsonian Drug for Positron Emission Tomography Imaging
    Xu, Yangyang
    Cen, Peili
    Ma, Lijuan
    Tian, Mei
    Zhang, Xue
    Zhang, Qinghua
    Yu, Kaiwu
    Zhang, Hong
    Gu, Wangjun
    He, Qinggang
    CHEMMEDCHEM, 2022, 17 (20)
  • [4] Radiosynthesis and Early Evaluation of a Positron Emission Tomography Imaging Probe [18F]AGAL Targeting Alpha-Galactosidase A Enzyme for Fabry Disease
    Lohith, Talakad G.
    Kaittanis, Charalambos
    Belanger, Anthony P.
    Ahn, Shin Hye
    Sandoval, Phil
    Cohen, Lawrence
    Rajarshi, Girija
    Ruangsiriluk, Wanida
    Islam, Rizwana
    Winkelmann, Christopher T.
    McQuade, Paul
    MOLECULES, 2023, 28 (20):
  • [5] Evaluation of [18F]pitavastatin as a positron emission tomography tracer for in vivo organic transporter polypeptide function
    Yagi, Yusuke
    Kimura, Hiroyuki
    Okuda, Haruka
    Ono, Masahiro
    Nakamoto, Yuji
    Togashi, Kaori
    Saji, Hideo
    NUCLEAR MEDICINE AND BIOLOGY, 2019, 74-75 : 25 - 31
  • [6] Positron-Emission Tomography Imaging of the TSPO with [18F]FEPPA in a Preclinical Breast Cancer Model
    Vasdev, Neil
    Green, David E.
    Vines, Douglass C.
    McLarty, Kristin
    McCormick, Patrick N.
    Moran, Matthew D.
    Houle, Sylvain
    Wilson, Alan A.
    Reilly, Raymond M.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2013, 28 (03) : 254 - 259
  • [7] Radiosynthesis and Preclinical Evaluation of an α2A-Adrenoceptor Tracer Candidate, 6-[18F]Fluoro-marsanidine
    Krzyczmonik, Anna
    Keller, Thomas
    Lopez-Picon, Francisco R.
    Forsback, Sarita
    Kirjavainen, Anna K.
    Takkinen, Jatta S.
    Wasilewska, Aleksandra
    Scheinin, Mika
    Haaparanta-Solin, Merja
    Saczewski, Franciszek
    Solin, Olof
    MOLECULAR IMAGING AND BIOLOGY, 2019, 21 (05) : 879 - 887
  • [8] [18F]-FDopa positron emission tomography imaging in corticobasal syndrome
    El Ouartassi, Anais
    Giordana, Caroline
    Schiazza, Aurelie
    Chardin, David
    Darcourt, Jacques
    BRAIN IMAGING AND BEHAVIOR, 2023, 17 (06) : 619 - 627
  • [9] Radiosynthesis and Preclinical Evaluation of m-[18F]FET and [18F]FET-OMe as Novel [18F]FET Analogs for Brain Tumor Imaging
    Groener, Benedikt
    Hoffmann, Chris
    Endepols, Heike
    Urusova, Elizaveta A.
    Brugger, Melanie
    Neumaier, Felix
    Timmer, Marco
    Neumaier, Bernd
    Zlatopolskiy, Boris D.
    MOLECULAR PHARMACEUTICS, 2024, 21 (06) : 2795 - 2812
  • [10] Re(CO)3([18F]FEDA), a novel 18F PET renal tracer: Radiosynthesis and preclinical evaluation
    Lipowska, Malgorzata
    Jarkas, Nashwa
    Voll, Ronald J.
    Nye, Jonathon A.
    Klenc, Jeffrey
    Goodman, Mark M.
    Taylor, Andrew T.
    NUCLEAR MEDICINE AND BIOLOGY, 2018, 58 : 42 - 50